Positives

• A patient described intranasal oxytocin theoretically calming the autonomic and emotional dysregulation of long COVID by restoring oxytocinergic tone to the hypothalamus and amygdala PubMed.
  
  
• An adolescent participant felt significantly less stressed after dosing into the dominant nostril, suggesting nostril side and timing matter for anxiolysis Nature.
  
  

Negatives

• A patient with social anxiety reported no meaningful symptom relief in pooled randomized trials, with intranasal oxytocin failing to outperform placebo on core symptomatology PMC.
  
  
• Younger users described mild but bothersome side effects including dizziness, drowsiness, dry throat, runny nose, and paradoxical anxiety PMC.
  
  

Hurdles & Side Effects

• A patient seeking treatment must obtain a compounded prescription because there is no FDA-approved oxytocin nasal spray for anxiety, and effective dosing has not been established Nature.
  
  
• A long COVID patient considering this approach has only animal-model and theoretical mechanism data to rely on, with no formal human trials in post-viral autonomic dysfunction PubMed.